Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Rivaroxaban

AOK Baden-Wurttemberg Germany has Released a tender for Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Rivaroxaban in Pharmaceuticals. The tender was released on Dec 06, 2024.

Country - Germany

Summary - Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Rivaroxaban

Deadline - login to view

MT reference number - 99175393

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99175393

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Agreement pursuant to Section 130a Paragraph 8 of the Social Security Code (SGB V) on the granting of discounts for patented drugs containing the active ingredient rivaroxaban (Xarelto®). An exact order value cannot be determined as thi s depends on various unknown factors. The order value for the contract awarded can therefore only be given as a fictitious value based on the currently applicable threshold values.local title:: Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zum Wirkstoff RivaroxabanContract Type: : Supplylocal description: : Vereinbarung gemäß § 130a Abs. 8 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit dem Wirksto

Mt Ref Id - 99175393

Deadline - Nov 30, -0001

Share

Similar Tenders :